knowledge -WSS

knowledge

author：hotspot 2025-09-27 13:10:57 - browse：925

Katie Palmer, STAT (left) moderating the Doctor vs. ChatGPT session during the 2023 STAT Summit. STAT

Generative AI tools are already helping doctors transcribe visits and summarize patient records. The technology behind ChatGPT, trained on vast amounts of data from the internet, made headlines when it correctly answered more than 80% of board exam questions. In July, a team at Beth Israel saw promising results when using GPT-4 during a diagnosis workshop for medical residents.

But the tool is by no means ready for primetime. When given questions about real-life medical scenarios by Stanford researchers, GPT frequently disagreed with humans or offered irrelevant information. The AI models are prone to “hallucinating,” or making things up because they sound right — a tendency that could cause immeasurable harm if let loose on patients. AI leaders and policymakers alike have called for more regulations.

STAT decided to put ChatGPT to the test at its annual summit on Wednesday, pitting the tool against Ann Woolley, infectious disease specialist at Brigham and Women’s Hospital. Marc Succi, the associate innovation chair at Mass General Brigham, gave two patient scenarios to the tool while Woolley explained her own diagnoses.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Hospitals owned by private equity see complications spike 25%

WSS

Grail spinoff by Illumina should end disastrous merger attempt

Christmas in the PICU brings some surprising joy

The cancer stories no one wants to hear

Heart disease in astronauts blamed on cosmic radiation

FDA scientists endorse Pfizer/BioNTech Covid

2 officers injured in shooting in Orlando, police say

focus

knowledge

focus

Apple is now the first public company to be valued at $3 trillion

2 officers injured in shooting in Orlando, police say

BioMarin wins approval for gene therapy to treat hemophilia A

Violet CEO on training clinicians to promote more inclusive care

BioMarin wins approval for gene therapy to treat hemophilia A

It costs an awful lot of money to give away a kidney

Malaria cases in Florida and Texas: Here’s what you need to know

Medicare slashes safety net hospital payments by nearly $1 billion

Tori Bowie and the unacceptable rates of Black maternal death

Virtual care provider acquires bankrupt Pear's prescription apps

focus

Keeping primary care docs in field isn't impossible, says AAFP CEO

Albert Bourla of Pfizer: worst biopharma CEO of 2023

CRISPR gene editing developments we’re watching in 2024

The a glaring gap in research on serious mental illness and primary care

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

HCA sued by state AG for quality issues at Mission Health

entertainment

hotspot

hotspot

Wikipedia